McKesson Cardiology Hemo software
Class II · Ongoing
Software defect concerning autosave mechanism may result in the clinician administering incorrect medication(s).
Advertisement
Advertisement
Affected lots / codes — check yours against thisSoftware versions: 13.1.2/No UDI, 13.2.1/UDI:(01)80010939050010, 14/(01)80010939050027,
- Recalling firm
- A L I Technologies Ltd, Burnaby,
- Classification
- Class II (temporary or reversible harm possible)
- Status
- Ongoing
- Quantity
- 1 unit
- Distribution
- US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, PA, SC, SD, TN, TX, WA, WI and the countries of Australia, Israel, Canada, Germany, Ireland, United Kingdom.
- Recall initiated
- December 2, 2024
- Classified
- January 16, 2025
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0957-2025%22
https://api.fda.gov/device/enforcement.json?search=recall_number%3A%22Z-0957-2025%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →